Sware

Chelsea, United States Founded: 2015 • Age: 11 yrs
Validation automation platform for regulated systems is provided.
Request Access

About Sware

Sware is a company based in Chelsea (United States) founded in 2015 by Kosal Keo.. Sware has raised $24.37 million across 4 funding rounds from investors including First Analysis, LRVHealth and New Stack Ventures. Sware offers products and services including Res_Q and GxPNext. Sware operates in a competitive market with competitors including RIMSYS, ValGenesis, Virtify, 3Aware and Essenvia, among others.

  • Headquarter Chelsea, United States
  • Founders Kosal Keo
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Sware, Inc.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $24.37 M (USD)

    in 4 rounds

  • Latest Funding Round
    $6.02 M (USD), Series B

    Apr 17, 2024

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Sware

Sware offers a comprehensive portfolio of products and services, including Res_Q and GxPNext. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Automates GxP validation processes to reduce costs and ensure compliance

Manages GxP requirements for life sciences through unified platforms

Funding Insights of Sware

Sware has successfully raised a total of $24.37M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $6.02 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 4
  • Last Round Series B — $6.0M
  • First Round

    (15 Jun 2020)

  • Investors Count 5
Date Amount Transaction Name Valuation Lead Investors Investors
Apr, 2024 Amount Series B - Sware Valuation First Analysis
Feb, 2022 Amount Series A - Sware Valuation

investors

May, 2021 Amount Series A - Sware Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Sware

Sware has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include First Analysis, LRVHealth and New Stack Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Venture capital and transaction advisory services for B2B tech companies.
Founded Year Domain Location
Early stage venture capital firm investing in the US
Founded Year Domain Location
Early-stage venture capital investments are made in innovative startups.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Sware

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Sware

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Sware Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Sware

Sware operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as RIMSYS, ValGenesis, Virtify, 3Aware and Essenvia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Medical device regulatory management software is provided for healthcare organizations.
domain founded_year HQ Location
Validation software is provided for life sciences companies.
domain founded_year HQ Location
Delivers content and compliance management software solutions.
domain founded_year HQ Location
Provider of real-world evidence platform for MedTech device safety and performance
domain founded_year HQ Location
Software for medical device pre- and post-market workflows is provided.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Sware

Frequently Asked Questions about Sware

When was Sware founded?

Sware was founded in 2015 and raised its 1st funding round 5 years after it was founded.

Where is Sware located?

Sware is headquartered in Chelsea, United States. It is registered at Chelsea, Massachusetts, United States.

Who is the current CEO of Sware?

Bryan Ennis is the current CEO of Sware.

Is Sware a funded company?

Sware is a funded company, having raised a total of $24.37M across 4 funding rounds to date. The company's 1st funding round was a Series A of $3.2M, raised on Jun 15, 2020.

What does Sware do?

A platform for validation automation in regulated systems was established in 2015 and is based in Chelsea, United States. Operations focus on the compliance technology sector, where the Res_Q system is utilized for lifecycle management and workflow automation. Compliance with regulated technology solutions is managed through these tools, supporting industries requiring strict validation protocols. Leadership includes a founder and CEO guiding development.

Who are the top competitors of Sware?

Sware's top competitors include RIMSYS, ValGenesis and 3Aware.

What products or services does Sware offer?

Sware offers Res_Q and GxPNext.

Who are Sware's investors?

Sware has 5 investors. Key investors include First Analysis, LRVHealth, New Stack Ventures, Insight Partners, and Jumpstart Foundry.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available